Home "Summer Surfing" Invitation: Call for Outstanding Digital Therapeutics Collaboration Cases for "Exploration of the Digital Therapeutics Industry"

"Summer Surfing" Invitation: Call for Outstanding Digital Therapeutics Collaboration Cases for "Exploration of the Digital Therapeutics Industry"

Jul 24, 2021 08:00 CST Updated 08:00

388715605536735903.jpg


2021 marked the inaugural year of digital therapeutics in China. Recently, the term “digital therapeutics” has appeared with increasing frequency in various healthcare industry conferences and reports, with interest in this field rapidly intensifying this summer!

 

In 2020, the pandemic served as a “catalyst,” accelerating the global development of digital therapeutics. Riding this wave, technologies such as big data, 5G, artificial intelligence, the Internet of Things (IoT), and blockchain have become more deeply integrated into the closed-loop healthcare ecosystem encompassing medical providers, patients, pharmaceuticals, medical devices, and insurance. Driven by the catalytic effect of the COVID-19 pandemic and strong support from digital health policies, digital therapeutics are opening up new frontiers in healthcare.

 

Digital therapeutics (DTx) products are validated by evidence-based medicine and built on application or artificial intelligence platforms. They can be integrated with wearable devices or medical devices to prevent, manage, or treat various diseases. DTx products can be utilized throughout the patient’s entire lifecycle, creating substantial opportunities for large-scale scenario-based applications in areas such as mental health, cognition, addiction cessation, diabetes, and respiratory diseases.

 

According to publicly available data compiled by VCBeat, there were over 70 digital therapeutics financing deals globally in the first half of 2021, with total funding exceeding $2.6 billion. THE EVIDENCE FORUM has further predicted that the digital therapeutics market size will grow tenfold within the next three to five years, potentially reaching $9 billion (approximately RMB 50 billion) by 2025.

 

The Blue Ocean of Digital Therapeutics Has Emerged! As one of the earliest institutions in China to focus on digital therapeutics, and as a supporting organization for the Digital Therapeutics Systems Engineering Professional Committee (Preparatory) of the China Association for Promotion of Rehabilitation Technology Transformation and Development—the first industrial association for digital therapeutics in China—VCBeat has been closely monitoring the transformative impact of digital therapeutics on the healthcare industry.

 

To better analyze the current state of digital therapeutics innovation in China and explore future innovative models, VCBeat and Eggshell Research Institute have jointly launched a call for outstanding collaborative case studies for “Exploring the Digital Therapeutics Industry” (tentative title), riding the summer wave of digital therapeutics!


Scope of Case Collection

Call for Innovative Digital Therapeutics Case Studies from Healthcare Institutions and Innovative Enterprises, with a Focus on Applications in Disease Prevention, Management, and Treatment, as Well as Partner Collaboration Cases


Selection Process

  1. Registration Period: July 24, 2021–August 24, 2021

  2. Selection Period: August 25, 2021 – September 25, 2021

Invite industry experts to form an editorial and review committee to conduct multi-dimensional analysis and evaluation of the preliminarily screened submitted cases, covering aspects such as product/service introduction, business model, technological innovation, and case outcomes.


Participation Rewards

1. Selected outstanding cases will be featured in the “Digital Therapeutics on the Fast Track” article series.Promoted across VCBeat’s official website, official WeChat account, and media matrix, reaching 300,000 industry professionals and over 1,000 investors, generating a total of more than 1 million media impressions.

 

2. VCBeat will organize experts to evaluate outstanding companies in the field of digital therapeutics,All submitted cases are eligible for inclusion in *Exploration of the Digital Therapeutics Industry* (tentative title), showcasing the company's innovative digital therapeutics applications to 300,000 industry-focused users.

 

“Exploration of the Digital Therapeutics Industry” (provisional title) will explore pathways, identify case studies, and develop benchmark models in adherence to relevant principles, actively advancing the practice of digital therapeutics in China. The report is scheduled for release around December at the First China Digital Therapeutics Annual Conference.


The annual conference is expected to draw 800 attendees, bringing together core stakeholders in digital therapeutics from both China and abroad—including research, clinical practice, industry, and investment sectors. It is the largest and most comprehensive digital therapeutics industry event in China.

 

3. Selected outstanding cases may be featured as benchmark examples and participate in the closed-door seminar of the Digital Therapeutics Industry China Tour.This closed-door seminar is hosted by the Digital Therapeutics Systems Engineering Professional Committee (Preparatory) of the China Association for Promotion of Rehabilitation Technology Translation and Development. Each session organizes core enterprises from China’s digital therapeutics value chain to visit and exchange insights with companies featuring exemplary case studies, discuss solutions to challenges encountered in corporate development, and explore opportunities for inter-enterprise collaboration.


Registration Channel

Complete Attachment 2, the Case Submission Form for the Table of Contents (Draft) of “Exploration of the Digital Therapeutics Industry,” and Attachment 3, the “Case Usage Authorization Letter,” truthfully.

 

Send electronic or scanned copies to: cdtsp@vcbeat.net

(If image documents or scanned copies are submitted, please also provide the corresponding electronic versions.)


Contact: Xiao Peiling Phone: 15223162186

 

Appendix 1: Table of Contents (Draft) of “Exploration of the Digital Therapeutics Industry”

Annex 2: Table of Contents (Draft) for “Exploration of the Digital Therapeutics Industry” – Case Submission Form

Appendix 3: “Case Usage Authorization Letter”

 

Invitation for Submission of Outstanding Collaboration Cases for “Exploring the Digital Therapeutics Industry” and Related Attachments: Please click the link or scan the QR code to download:https://pan.baidu.com/s/14K4WiacAbaErKqw3OreCzA(Extraction code: ViC1)

0ae51f6ebf30402e8f3e16750670626.jpg